164 related articles for article (PubMed ID: 15966146)
1. Validation.
Isaacs A
Med Device Technol; 2001 Dec; 12(10):38, 40. PubMed ID: 15966146
[TBL] [Abstract][Full Text] [Related]
2. Integrating risk management into the CAPA process.
Bills E; Tartal J
Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
[No Abstract] [Full Text] [Related]
3. How to kick-start your CAPA process.
Peterson K
Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
[No Abstract] [Full Text] [Related]
4. Preparing for more active market surveillance.
Donawa M
Med Device Technol; 2005 May; 16(4):30-3. PubMed ID: 15941197
[TBL] [Abstract][Full Text] [Related]
5. Review of the Medical Device Directive.
Donawa M
Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
[TBL] [Abstract][Full Text] [Related]
6. The impact of the revised electromagnetic compatibility standard.
Bozec D; Hayes DJ
Med Device Technol; 2004 Oct; 15(8):33-4, 36. PubMed ID: 16225272
[TBL] [Abstract][Full Text] [Related]
7. FDA pilot programme in support of global harmonisation.
Donawa ME
Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
[TBL] [Abstract][Full Text] [Related]
8. What is in the QSR/GMP?
Bartoo G;
IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
[No Abstract] [Full Text] [Related]
9. Validation and Six Sigma.
Barry E
Med Device Technol; 2008; 19(7):36, 38-40. PubMed ID: 19133627
[TBL] [Abstract][Full Text] [Related]
10. The IVD directive: late-phase practicalities.
Johnson P; Walker R
Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
[No Abstract] [Full Text] [Related]
11. How FDA-recognized standards impact users, manufacturers.
Osborn D
Biomed Instrum Technol; 2009; 43(2):156-7. PubMed ID: 19480488
[No Abstract] [Full Text] [Related]
12. Risk management.
Bartoo G
IEEE Eng Med Biol Mag; 2003; 22(4):166-70, 172. PubMed ID: 14515712
[TBL] [Abstract][Full Text] [Related]
13. European requirements for product returns.
Donawa M
Med Device Technol; 2005 Nov; 16(9):28-31. PubMed ID: 16438446
[TBL] [Abstract][Full Text] [Related]
14. How to validate a packaging process.
Turner M
Med Device Technol; 2004 Mar; 15(2):20-3. PubMed ID: 15154335
[TBL] [Abstract][Full Text] [Related]
15. Effective risk management programmes.
Donawa M
Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
[TBL] [Abstract][Full Text] [Related]
16. Meeting US and European supplier control requirements.
Donawa M
Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
[TBL] [Abstract][Full Text] [Related]
17. Applying the new medical collateral EMC standard EN60601-1-2:2001.
Bearpark J
Med Device Technol; 2005 Sep; 16(7):24-5. PubMed ID: 16259156
[TBL] [Abstract][Full Text] [Related]
18. Implementing new European vigilance procedures.
Donawa M
Med Device Technol; 2007; 18(7):34, 36-7. PubMed ID: 18075133
[TBL] [Abstract][Full Text] [Related]
19. Addressing US and European device testing requirements.
Donawa M
Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
[TBL] [Abstract][Full Text] [Related]
20. Combination products and the role of medical device firms.
Etheredge R
Biomed Instrum Technol; 2005; 39(2):143-6. PubMed ID: 15810788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
